Skip to main content
. 2019 Aug 26;37(30):2769–2777. doi: 10.1200/JCO.18.01972

FIG A2.

FIG A2.

(A) and (B) Event-free survival for AREN0533 lung metastases only, treated with DD4A and a complete response after induction, by loss of heterozygosity (LOH) of 1p and 16q. (C) and (D) Event-free survival for AREN0533 lung metastases only, treated with Regimen M and an incomplete response after induction, by loss of heterozygosity (LOH) of 1p and 16q.